NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
18.90
+0.20 (1.07%)
At close: May 16, 2025, 4:00 PM
18.51
-0.39 (-2.06%)
After-hours: May 16, 2025, 6:05 PM EDT
NAMS Market Cap
NAMS has a market cap or net worth of $2.12 billion as of May 16, 2025. Its market cap has increased by 8.09% in one year.
Market Cap
2.12B
Enterprise Value
1.31B
1-Year Change
8.09%
Ranking
Category
Stock Price
$18.90
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $2.12B, an increase of 1,272.40%. That is a compound annual growth rate of 84.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2025 | 2.10B | -23.69% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 642.38B |
| Johnson & Johnson | 352.15B |
| AbbVie | 313.43B |
| Novo Nordisk | 288.64B |
| UnitedHealth Group | 279.41B |
| Abbott Laboratories | 223.67B |
| Novartis AG | 208.47B |
| AstraZeneca | 206.71B |